Suita, Japan

Tatsuhiko Kono


Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 80(Granted Patents)


Location History:

  • Kyoto, JA (1977)
  • Kyoto, JP (1979)
  • Suita, JP (1980 - 1987)

Company Filing History:


Years Active: 1977-1987

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tatsuhiko Kono

Introduction: Tatsuhiko Kono, a prominent inventor based in Suita, Japan, has made significant strides in the field of pharmaceuticals. With a total of five patents under his name, Kono has focused on developing compounds with various medical applications, notably in treating inflammatory and allergic conditions.

Latest Patents: Among Kono's recent innovations are patents for 4-quinolone derivatives known for their anti-inflammatory, anti-allergic, antitussive, expectorant, and antithrombotic activities. These pharmaceutical compositions not only highlight the compounds themselves but also the methods for treating both humans and animals using these derivatives. Another notable patent involves the 4-hydroxy-3-benzoyl-2-quinolone derivatives, which similarly exhibit anti-inflammatory and anti-allergenic properties, emphasizing Kono’s commitment to advancing medical treatments.

Career Highlights: Tatsuhiko Kono is associated with Nippon Shinyaku Company, Ltd., where his research and development efforts have contributed meaningfully to the company’s portfolio. His innovative spirit and dedication to improving health outcomes have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations: Kono works alongside esteemed colleagues such as Hiroshi Enomoto and Yoshiaki Aoyagi. Their collaborative efforts are key to driving forward the research and development of new pharmaceutical products that address complex health issues.

Conclusion: Tatsuhiko Kono’s inventions and patents reflect a deep commitment to enhancing medical therapies through innovative compounds. His work at Nippon Shinyaku Company, Ltd., along with his collaborations, continues to push the boundaries of what is possible in the field of pharmaceuticals, paving the way for effective treatments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…